Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.94 USD | +10.67% | +8.10% | +620.67% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- MarketScreener Editorial Features